Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

418 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Therapy of active Crohn disease with Boswellia serrata extract H 15].
Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Gerhardt H, et al. Among authors: vogelsang h. Z Gastroenterol. 2001 Jan;39(1):11-7. doi: 10.1055/s-2001-10708. Z Gastroenterol. 2001. PMID: 11215357 Clinical Trial. German.
H 15 was tested on non-inferiority compared to standard treatment with mesalazine. RESULTS: The CDAI between the status of enrolment and end of therapy after treatment with H15 was reduced by 90 and after therapy with mesalazine by 53 scores in the mean. ...
H 15 was tested on non-inferiority compared to standard treatment with mesalazine. RESULTS: The CDAI between the status of enrolment
[Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases].
Miehsler W, Dejaco C, Gröchenig HP, Fuchssteiner H, Högenauer C, Kazemi-Shirazi L, Maier H, Mayer A, Moschen A, Reinisch W, Petritsch W, Platzer R, Steiner P, Tilg H, Vogelsang H, Wenzl H, Novacek G. Miehsler W, et al. Among authors: vogelsang h. Z Gastroenterol. 2018 Mar;56(3):275-302. doi: 10.1055/s-0044-100044. Epub 2018 Mar 12. Z Gastroenterol. 2018. PMID: 29529682 German.
[Response prediction: molecular approaches and routine clinical care].
Vogelsang H, Keller G, Ott K, Theisen J, Weber W, Fink U, Becker K, Höfler H, Siewert JR. Vogelsang H, et al. Z Gastroenterol. 2003 Mar;41 Suppl 1:S18-9. doi: 10.1055/s-2003-37428. Z Gastroenterol. 2003. PMID: 12664335 German. No abstract available.
Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.
Lochs H, Adler G, Beglinger C, Duchmann R, Emmrich J, Ewe K, Gangl A, Gasché C, Hahn E, Hoffmann P, Kaskas B, Malchow H, Pohl C, Raedler A, Renner E, Schölmerich J, Schreiber S, Stange E, Tilg H, Vogelsang H, Weigert N, Zeitz M. Lochs H, et al. Among authors: vogelsang h. Z Gastroenterol. 1999 Jun;37(6):509-12. Z Gastroenterol. 1999. PMID: 10427657 Clinical Trial.
[Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].
Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Tilg H. Dejaco C, et al. Among authors: vogelsang h. Z Gastroenterol. 2006 Jun;44(6):525-38; discussion 539. doi: 10.1055/s-2006-926796. Z Gastroenterol. 2006. PMID: 16773519 Review. German.
[Consensus of the Chronic Inflammatory Bowl Disease Study Group of the Austrian Society of Gastroenterology and Hepatology on the topic of "diagnosis and therapy of chronic inflammatory bowel diseases in adolescence"].
Vogelsang H, Granditsch G, Binder C, Herbst F, Moser G, Petritsch W, Knoflach P. Vogelsang H, et al. Z Gastroenterol. 2000 Sep;38(9):791-4. doi: 10.1055/s-2000-7524. Z Gastroenterol. 2000. PMID: 11072675 Review. German.
[Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].
Reinisch W, Haas T, Kaser A, Petritsch W, Vogelsang H, Feichtenschlager T, Novacek G, Siebert F, Tilg H, Knoflach P. Reinisch W, et al. Among authors: vogelsang h. Z Gastroenterol. 2009 Apr;47(4):372-80. doi: 10.1055/s-0028-1109218. Epub 2009 Apr 8. Z Gastroenterol. 2009. PMID: 19358065 German.
Vedolizumab in der Behandlung der Colitis ulcerosa und des Morbus Crohn - ein Konsensus der Arbeitsgruppe "Chronisch Entzündliche Darmerkrankungen" der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie.
Novacek G, Dejaco C, Gröchenig HP, Högenauer C, Knoflach P, Miehsler W, Moschen A, Petritsch W, Vogelsang H, Tilg H. Novacek G, et al. Among authors: vogelsang h. Z Gastroenterol. 2016 May;54(5):456-67. doi: 10.1055/s-0042-103694. Epub 2016 Mar 16. Z Gastroenterol. 2016. PMID: 26982099 German. No abstract available.
[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH].
Fuchssteiner H, Nigl K, Mayer A, Kristensen B, Platzer R, Brunner B, Weiß I, Haas T, Benedikt M, Gröchenig HP, Eisenberger A, Hillebrand P, Reinisch W, Vogelsang H. Fuchssteiner H, et al. Among authors: vogelsang h. Z Gastroenterol. 2014 Apr;52(4):376-86. doi: 10.1055/s-0034-1366252. Epub 2014 Apr 9. Z Gastroenterol. 2014. PMID: 24718944 German.
[Adalimumab for the treatment of ulcerative colitis--a consensus report by the working group inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Novacek G, Dejaco C, Knoflach P, Moschen A, Petritsch W, Vogelsang H, Reinisch W. Novacek G, et al. Among authors: vogelsang h. Z Gastroenterol. 2014 Feb;52(2):204-11. doi: 10.1055/s-0033-1355818. Epub 2014 Jan 31. Z Gastroenterol. 2014. PMID: 24488763 German.
418 results
Jump to page
Feedback